SCHEMBL8910758

SCHEMBL8910758

CC1=C(C(=O)OCc2ccccc2)N=c2cc3c(c(C)c21)=Nc1cc(F)ccc1-3

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHODH Q02127 1/20 0.38
MAPT P10636 8/20 0.36
KMT2A Q03164 3/20 0.36
TDP1 Q9NUW8 2/20 0.36
SLC6A2 P23975 1/20 0.36
SLC6A3 Q01959 1/20 0.36
PKM P14618 1/20 0.36
KDM4E B2RXH2 2/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
AR P10275 1/20 0.35
RAB9A P51151 5/20 0.35
NPC1 O15118 3/20 0.35
PTGDR2 Q9Y5Y4 1/20 0.35
LMNA P02545 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
ALDH1A1 P00352 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8909720 0.92 DHODH (0.38) DHODHMAPTKMT2ATDP1SLC6A2
SCHEMBL1388713 0.89 TDP1 (0.40) MAPTKMT2ATDP1SLC6A2SLC6A3
SCHEMBL8909595 0.83 DHODH (0.38) DHODHMAPTKMT2ATDP1SLC6A2
SCHEMBL8909637 0.82 TDP1 (0.40) DHODHMAPTKMT2ATDP1SLC6A2
SCHEMBL8911173 0.81 TDP1 (0.39) MAPTKMT2ATDP1SLC6A2SLC6A3
SCHEMBL8909809 0.80 TSHR (0.37) MAPTKMT2AL3MBTL1CYP1A2CYP2D6
SCHEMBL9434331 0.76 TDP1 (0.36) DHODHMAPTKMT2ATDP1SLC6A2
SCHEMBL8150300 0.76 MAPK1 (0.33) PPARG
SCHEMBL8910217 0.74 TDP1 (0.44) MAPTKMT2ATDP1SLC6A2SLC6A3
SCHEMBL8155106 0.74 MAOB (0.43) MAPTKMT2ATDP1L3MBTL1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5679694-A LOW TOXICITY AGAINST NORMAL CELL LINES THE WELLCOME FOUNDATION LTD. (GB) 1997-10-21 US disclosed